Unknown

Dataset Information

0

MicroRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response.


ABSTRACT: Sentinel node biopsy (SNB) is a main staging biomarker in melanoma and is the first lymph node to drain the tumor, thus representing the immunological site where anti-tumor immune dysfunction is established and where potential prognostic immune markers can be identified. Here we analyzed microRNA (miR) profiles in archival tumor-positive SNBs derived from melanoma patients with different outcomes and performed an integrated analysis of transcriptional data to identify deregulated immune signaling networks. Twenty-six miRs were differentially expressed in melanoma-positive SNB samples between patients with disease progression and non-progressing patients, the majority being previously reported in the regulation of immune responses. A significant variation in miR expression levels was confirmed in an independent set of SNB samples. Integrated information from genome-wide transcriptional profiles and in vitro assessment in immune cells led to the identification of miRs associated with the regulation of the TNF receptor superfamily member 8 (TNFRSF8) gene encoding the CD30 receptor, a marker increased in lymphocytes of melanoma patients with progressive disease. These findings indicate that miRs are involved in the regulation of pathways leading to immune dysfunction in the sentinel node and may provide valuable markers for developing prognostic molecular signatures for the identification of stage III melanoma patients at risk of recurrence.

SUBMITTER: Vallacchi V 

PROVIDER: S-EPMC5192500 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response.

Vallacchi Viviana V   Camisaschi Chiara C   Dugo Matteo M   Vergani Elisabetta E   Deho Paola P   Gualeni Ambra A   Huber Veronica V   Gloghini Annunziata A   Maurichi Andrea A   Santinami Mario M   Sensi Marialuisa M   Castelli Chiara C   Rivoltini Licia L   Rodolfo Monica M  

Genes 20161214 12


Sentinel node biopsy (SNB) is a main staging biomarker in melanoma and is the first lymph node to drain the tumor, thus representing the immunological site where anti-tumor immune dysfunction is established and where potential prognostic immune markers can be identified. Here we analyzed microRNA (miR) profiles in archival tumor-positive SNBs derived from melanoma patients with different outcomes and performed an integrated analysis of transcriptional data to identify deregulated immune signalin  ...[more]

Similar Datasets

| S-EPMC4984404 | biostudies-literature
| S-EPMC3928050 | biostudies-literature
| S-EPMC7803563 | biostudies-literature
| S-EPMC9225330 | biostudies-literature
| S-EPMC3598232 | biostudies-literature
| S-EPMC4517810 | biostudies-literature
| S-ECPF-GEOD-24067 | biostudies-other
| S-EPMC4178297 | biostudies-literature
| S-EPMC3882943 | biostudies-literature
| S-EPMC10398358 | biostudies-literature